We use cookies to collect information about how you use GOVUnited Kingdom We use this information to make the website the best we can and to improve government services

The COVID-19 vaccine developed by Moderna was approved for delivery today by the Medicines and Health Products Regulatory Authority (MHRA) This follows a thorough and rigorous assessment by the MHRA’s teams of scientists, including the recommendations of the Independent Commission for Medicinal Products for Human Use, which reviewed all the data thoroughly to ensure that this vaccine met the required standards of safety, quality and effectiveness

This is the third COVID-19 vaccine approved by the MHRA and the second mRNA vaccine (the Pfizer / BioNTech vaccine approved in December 2020 is also an mRNA vaccine)

Today’s approval brings more encouraging news to the public and the health sector, and I am proud that the agency will approve a third COVID-19 vaccine for delivery after a thorough and thorough evaluation of all available data is an important goal helped make this a reality

While the advances we are now making on vaccines at a regulatory level are not contributing to this, we are helping in our global fight against this disease and ultimately helping to save lives I want to reiterate that our goal is always to Put the protection of the public first

Once used, all COVID-19 vaccines are continuously monitored by the MHRA, ensuring that the benefits in protecting people from COVID-19 far outweigh any potential side effects
In the meantime, even if you’ve received a vaccine, it’s important for everyone to abide by national lockdown restrictions and to remind themselves at all times to “stay vigilant, protect the NHS and save lives”

We are pleased to make a positive recommendation for the Moderna vaccine, which will be helpful in introducing the COVID-19 vaccination program

As with all COVID-19 vaccine data seen to date, we have ensured that a reliable and thorough safety assessment has been conducted with the independent experts belonging to this group

This Moderna vaccine injects a small portion of the genetic code of the COVID-19 virus that triggers an immune response and creates antibodies in the human body that can fight the virus The dosage for this specific vaccine requires the administration of two doses of Es It is recommended to give the second dose 28 days after the first.It is approved for use in people aged 18 years and over and can be used by pregnant and breastfeeding women after discussing the benefits and risks with their doctor.It can last up to six months be stored at -20 ° C

The National Institute for Biological Standards and Control, which is part of the agency, conducts independent batch release for all approved vaccines to ensure that each batch meets quality standards, including the Moderna COVID-19 vaccine

In accordance with the other approved COVID-19 vaccines, the Moderna vaccine should only be considered for use in pregnancy if the potential benefits outweigh the potential risks to the mother and child. Women should consider the benefits and risks Discuss a vaccine with their healthcare professional and make a mutual decision based on individual circumstances. Women who are breastfeeding may receive the vaccine even after speaking with their healthcare professional

People with a history of allergic reactions to any of the ingredients in the vaccine should not receive them People with other allergies like food allergies can get the vaccine

E-mail
newscentre @ mhraGovernmentUnited Kingdom

During office hours:
020 3080 7651 (8.30 a.m. – 5 p.m.)

Outside office hours:
07770 446 189 (17:00 – 08:30)

Office hours are Monday through Friday from 8:30 a.m. to 5:00 p.m. Current updates in real time, including the latest press releases and press releases, can be found on our Twitter channel at https: // wwwTwittercom / mhragovuk

To help us improve the GOV UK, today we’d like to know more about your visit We’ll send you a link to a feedback form It only takes 2 minutes to fill out Don’t worry, we won’t spam you or give you your email Mail address to no one else

Open Government License

Moderna Vaccine

World News – UK – Moderna vaccine becomes third COVID-19 vaccine to be approved by UK regulatory agency

Source: https://www.gov.uk/government/news/moderna-vaccine-becomes-third-covid-19-vaccine-approved-by-uk-regulator